Amneal Pharmaceuticals (AMRX)
(Delayed Data from NSDQ)
$9.81 USD
0.00 (0.00%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $9.82 +0.01 (0.10%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth B Momentum A VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
AMRX 9.81 0.00(0.00%)
Will AMRX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for AMRX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AMRX
Wall Street Analysts Think Amneal (AMRX) Could Surge 25.52%: Read This Before Placing a Bet
Rigel Pharmaceuticals, Inc. (RIGL) Soars to 52-Week High, Time to Cash Out?
AMRX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts See a 27.66% Upside in Amneal (AMRX): Can the Stock Really Move This High?
Are Medical Stocks Lagging Boston Scientific (BSX) This Year?
Here's Why Momentum in Amneal (AMRX) Should Keep going
Other News for AMRX
Is AMRX preparing for a move? NR7 shows up after a flat session
Is AMRX primed for upward momentum? Crossed Above 20 Day Moving Average shows up after climbing 2.08%
AMRX Fell Below 20 Day Moving Average on September 18
TPG GP A, LLC Reduces Stake in Life Time Group Holdings Inc
AMRX forms 1,2,3 Pullback Bullish on September 16